Parag Desai appointed Head of Marketing Excellence at Alembic Pharma

By: IPP Bureau

Last updated : September 14, 2026 7:48 am



With a career spanning nearly three decades, Desai has focused on driving marketing productivity, strengthening sales effectiveness and aligning commercial initiatives with broader organisational goals


Parag Desai has been appointed Head of Marketing Excellence at Alembic Pharmaceuticals Limited, taking on a strategic leadership role focused on strengthening marketing effectiveness, business productivity and strategic execution.

Desai brings more than 28 years of experience in the pharmaceutical industry, with expertise spanning sales, sales effectiveness, hospital sales, marketing, business excellence, strategy, digital transformation and business development.

Prior to joining Alembic Pharmaceuticals in his new role, Desai served as Director (Vice President) at Emcure Pharmaceuticals, a position he took up in January 2025. 

At Emcure, he focused on strategic initiatives aimed at enhancing marketing productivity, operational excellence and sustainable business growth. 

Earlier in his career, Desai held leadership positions at Cipla, Alembic Pharmaceuticals and Zydus Group, gaining extensive experience across pharmaceutical sales and marketing, commercial strategy and business excellence. 

With a career spanning nearly three decades, Desai has focused on driving marketing productivity, strengthening sales effectiveness and aligning commercial initiatives with broader organisational goals.

In his new role at Alembic Pharmaceuticals, he is expected to focus on enhancing marketing capabilities, improving execution and supporting the company's growth objectives through a stronger emphasis on marketing excellence and operational effectiveness.

Desai’s return to Alembic marks another significant step in a career that has combined commercial leadership with a strong focus on business transformation and sustainable growth in the pharmaceutical sector.

Parag Desai marketing Alembic Pharma Emcure Pharma Zydus Cipla business excellence strategy digital transformation

First Published : September 14, 2026 12:00 am